Latest News & Features
Americas
German life sciences company Bayer has completed the $66 billion buyout of agricultural corporation Monsanto, a week after the US government announced Bayer must divest $9 billion worth of assets for the deal to proceed. 7 June 2018
Americas
Private capital must finance the life sciences industry in the US otherwise the country will lose its advantage in the life sciences field, claimed Jonathan Kraft, president of The Kraft Group. 7 June 2018
Americas
Actor and director Rob Reiner first realised his son Nick had problems with drugs when he was 14 years old after Nick’s friend passed out after taking drugs with him. 7 June 2018
Big Pharma
GSK has confirmed that its $13 billion buyout of Novartis from the companies’ consumer healthcare joint venture has been completed following approval from shareholders. 7 June 2018
Americas
Pfizer Canada has announced a C$1.2 million (US$931,000) investment for the Neomed Institute in an effort to accelerate transforming scientific discoveries from Canadian universities into innovative therapeutic treatments. 6 June 2018
Americas
“I have a message for all of you searching for a treatment and a cure in your lifetime; I hope you can look at my story and know that anything is possible,” said Ashanti DeSilva to attendees at the 2018 BIO International Convention. 6 June 2018
Americas
In 2007, Robin Roberts, co-anchor for ABC News’s Good Morning America show, was diagnosed with breast cancer. Five years later, she was diagnosed with myelodysplastic syndrome, a disease of the blood and bone marrow once known as pre-leukaemia. 6 June 2018
Americas
Why has the US Supreme Court never granted certiorari on the issue of differing standards required to prove patent invalidity at district courts and at the US Patent and Trademark Office (USPTO)? 6 June 2018
Americas
“It is my firm belief that folks on all sides need to stop relentlessly bashing the [patent] system if they want it to succeed.” 5 June 2018
Europe
C5’s International Pharma Patent Term Extensions Forum, which will be held in Munich, Germany on June 19 and 20, will provide guidance on patent term extensions in the world’s key IP regions, as LSIPR finds out. 4 June 2018